International Conference on Advanced Pulmonology, Respiratory Medicine & Lung Health
June 25-27, 2026 | Barcelona, Spain
Pleural Diseases
Emerging imaging tools and procedural techniques have refined the diagnosis and treatment of pleural diseases, including pleural effusion, empyema, pneumothorax, and malignant mesothelioma. Ultrasound-guided thoracentesis, pleural manometry, and indwelling pleural catheters are transforming patient care by reducing complications and enabling ambulatory management. Thoracoscopy remains a cornerstone for diagnosing unexplained effusions and administering talc pleurodesis. Pleural diseases research now focuses on molecular profiling of pleural fluid and minimally invasive biomarkers to improve diagnostic yield. Multidisciplinary input from pulmonologists, thoracic surgeons, and radiologists ensures accurate assessment and tailored treatment plans. Enhanced guidelines and procedural training are improving safety and outcomes across both inpatient and outpatient care environments.
Yong Xiao Wang
Albany Medical College, United States
Ranjan Ramasamy
ID-FISH Technology, United States
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Stanley P Galant
University of California Irvine, United States
Mariano Votta
Active Citizenship Network (Cittadinanzattiva), Italy
Emma Borrelli
University of Siena, Italy
Monika Osko
Orthodontic World Institute, University of Barcelona, SpainSubmit your abstract Today
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Non-canonical IRF3 functions in limiting pulmonary inflammation
Saurabh Chattopadhyay, University of Kentucky, United States
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : The representational challenge for designing and managing intelligent and ethical 5P medicine pulmonary, respiratory and lung health care systems
Habil Bernd Blobel, University of Regensburg, Germany
Title : From Chronic Obstructive Pulmonary Disease (COPD) to Non-Small Cell Lung Cancer (NSCLC): T helper cell epigenetic modifications and cancer risk
Koustav Sarkar, SRM Institute of Science and Technology, India
Title : Bacterial profile of community acquired pneumonia in a public health institute
Sayan Bhattacharyya, AIIH&PH, India